Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá

132 páginas : gráficas

Autores:
Linares González, Yanis Milena
Aguilar Rodriguez, Argelis Mairena
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2019
Institución:
Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
Repositorio:
Repositorio Institucional UDCA
Idioma:
spa
OAI Identifier:
oai:repository.udca.edu.co:11158/1953
Acceso en línea:
https://repository.udca.edu.co/handle/11158/1953
Palabra clave:
Farmacoterapia oncológica
Agentes neoplásicos
Medicamentos - Abastecimiento y distribución
Rights
openAccess
License
Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales
id RepoUDCA2_b2f18c6e43d905bbb2e410b8faf4b926
oai_identifier_str oai:repository.udca.edu.co:11158/1953
network_acronym_str RepoUDCA2
network_name_str Repositorio Institucional UDCA
repository_id_str
dc.title.spa.fl_str_mv Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
title Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
spellingShingle Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
Farmacoterapia oncológica
Agentes neoplásicos
Medicamentos - Abastecimiento y distribución
title_short Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
title_full Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
title_fullStr Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
title_full_unstemmed Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
title_sort Evaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá
dc.creator.fl_str_mv Linares González, Yanis Milena
Aguilar Rodriguez, Argelis Mairena
dc.contributor.advisor.spa.fl_str_mv Vanegas Escamilla, Egdda Patricia, dir.
dc.contributor.author.spa.fl_str_mv Linares González, Yanis Milena
Aguilar Rodriguez, Argelis Mairena
dc.subject.mesh.spa.fl_str_mv Farmacoterapia oncológica
Agentes neoplásicos
Medicamentos - Abastecimiento y distribución
topic Farmacoterapia oncológica
Agentes neoplásicos
Medicamentos - Abastecimiento y distribución
description 132 páginas : gráficas
publishDate 2019
dc.date.accessioned.spa.fl_str_mv 2019-08-12T22:38:25Z
dc.date.available.spa.fl_str_mv 2019-08-12T22:38:25Z
dc.date.issued.spa.fl_str_mv 2019
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/TP
format http://purl.org/coar/resource_type/c_7a1f
status_str publishedVersion
dc.identifier.uri.spa.fl_str_mv https://repository.udca.edu.co/handle/11158/1953
dc.identifier.local.spa.fl_str_mv QF045 L35e 2019 (205619)
url https://repository.udca.edu.co/handle/11158/1953
identifier_str_mv QF045 L35e 2019 (205619)
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Drug shortages roundtable: Minimizing the impact on patient care. Am J Heal Pharm[Internet]. 2018 Jun 1 [cited 2019 Feb 11];75(11):816–20. Available from: https://academic.oup.com/ajhp/article/75/11/816-820/5102302
Servicios Oncológicos en Colombia. Rev Colomb Cancerol. 2013;14(1):52.
A ALPS. Título: REPORTE DE CASO DESABASTECIMIENTO Metotrexato 500 mg inyectable Autor / Dependencia: Dirección de Medicamentos y Tecnologías en Salud Ciudad: Bogotá Fecha: 28/12/2017. 2017;28–9.
Aguilar Gavira S, Barroso Osuna J. La triangulación de datos como estrategia en investigación educativa. Píxel-Bit, Rev Medios y Educ. 2015;
Alevizakos M, Detsis M, Grigoras CA, Machan JT, Mylonakis E. The Impact of Shortages on Medication Prices: Implications for Shortage Prevention. Drugs. 2016;76(16):1551–8.
Alruthia YS, Alwhaibi M, Alotaibi MF, Asiri SA, Alghamdi BM, Almuaythir GS, et al. Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi Pharm J [Internet]. 2018;26(7):947–51. Available from: https://doi.org/10.1016/j.jsps.2018.05.002
AlRuthia YS, AlKofide H, AlAjmi R, Balkhi B, Alghamdi A, AlNasser A, et al. Drug shortages in large hospitals in Riyadh: a cross-sectional study. Ann Saudi Med [Internet]. 2017 Sep [cited 2019 Feb 11];37(5):375–85. Available from: http://www.annsaudimed.net/index.php/vol37/vol37iss5/4657.html
Alsheikh M, Seoane-Vazquez E, Rittenhouse B, Fox ER, Fanikos J. A Comparison of Drug Shortages in the Hospital Setting in the United States and Saudi Arabia: An Exploratory Analysis. Hosp Pharm [Internet]. 2016;51(5):370–5. Available from: http://journals.sagepub.com/doi/10.1310/hpj5105-370
American College of Medical Toxicology, American Academy of Clinical Toxicology. Antidote Shortages in the USA: Impact and Response. J Med Toxicol. 2015;11(1):144–6.
Asamblea Mundial de la Salud 70. La escasez mundial de medicamentos y vacunas y el acceso a ellos: informe de la Secretaría. 2017;2:1–9. Available from: http://apps.who.int/iris/handle/10665/274800%0Ahttp://apps.who.int/iris/bitstream/10665/274800/1/A70_20-sp.pdf
Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2013;
Bochenek T, Abilova V, Alkan A, Asanin B, Beriain I de M, Besovic Z, et al. Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian Countries. Front Pharmacol. 2018;8(JAN).
Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, et al. Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa. Trop Med Int Heal. 2017;
Cáncer DEL. Plan Decena Para El Control Del Cáncer En Colombia 2012-2021 [Internet]. 2012. Available from: https://www.minsalud.gov.co/Documentos y Publicaciones/Plan Decenal para el Control del Cáncer.pdf
Casas Anguita J, Repullo Labrador JR, Donado Campos J. La encuesta como técnica de investigación. Elaboración de cuestionarios y tratamiento estadístico de los datos (I). Aten Primaria. 2003;
Castellanos L. EVOLUCIÓN DEL MERCADO FARMACÉUTICO CON RELACIÓN AL DESABASTECIMIENTO DE LOS MEDICAMENTOS ONCOLÓGICOS EN COLOMBIA. 2019;
Castrellón-Torres JP, Torres-Acosta JH, Adarme-Jaimes W. Model for the logistics distribution of medicines in the Colombian public health program. DYNA. 2014;
Caulder C, Mehta B, Bookstaver P, Sims L, Stevenson B, South Carolina Society of Health-Sy. Impact of Drug Shortages on Health System Pharmacies in the Southeastern United States. Hosp Pharm [Internet]. 2015;50(4):279–86. Available from: http://archive.hospital-pharmacy.com/doi/abs/10.1310/hpj5004-279
Ceballos MM. Manual para el desarrollo del mapeo de actores claves–MAC. Elabor en el marco la Consult técnica GITEC-SERCITEC. 2004;
Chen SI. Economic benefits of sharing and redistributing influenza vaccines when shortages occurred. PLoS One. 2017;
Choi JB, Rogers J, Jones EC. The impact of a shared pharmaceutical supply chain model on counterfeit drugs, diverted drugs, and drug shortages. In: Portland International Conference on Management of Engineering and Technology. 2015.
Claus B, Bauters T, Laureys G. Drug shortages in a pediatric stem cell transplantation ward: Challenges and implications. A 5-year bilan. J Oncol Pharm Pract. 2018;
Claus B, Pauwels K, Baert M, Depoorter J, De Weerdt E, Boussery K, et al. [Drug shortages in the hospital: management, causes and budget impact]. J Pharm Belg. 2015;
De Weerdt E, De Rijdt T, Simoens S, Casteels M, Huys I. Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study. PLoS One. 2017;
De Weerdt E, Simoens S, Casteels M, Huys I. Clinical, Economic and Policy Implications of Drug Shortages in the European Union. Appl Health Econ Health Policy. 2017;15(4):441–5.
De Weerdt E, Simoens S, Casteels M, Huys I. Toward a European definition for a drug shortage: A qualitative study. Front Pharmacol. 2015;
de Weerdt E, Simoens S, Casteels M, Huys I. Clinical, Economic and Policy Implications of Drug Shortages in the European Union. Appl Health Econ Health Policy. 2016;1–5.
De Weerdt E, Simoens S, Hombroeckx L, Casteels M, Huys I. Causes of drug shortages in the legal pharmaceutical framework. Regul Toxicol Pharmacol [Internet]. 2015;71(2):251–8. Available from: http://dx.doi.org/10.1016/j.yrtph.2015.01.005
De I. Informe de gestión del desabastecimiento de medicamentos en Colombia 2013-2018. 2018;
Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG. Drug tendering: Drug supply and shortage implications for the uptake of biosimilars. ClinicoEconomics and Outcomes Research. 2017.
Estadístico De Datos A, Franco TL, Hidalgo R. Análisis Estadístico de Datos de Caracterización Morfológica de Recursos Fitogenéticos. Boletin Técnico Nro 8, Instituto Internacional de Recursos Fitogenéticos IPGRI. 2003
Fecha M, Suministro D, Esmeralda ASA, Regulatory AM, Manager A, M- I, et al. Título: REPORTE DE CASO DESABASTECIMIENTO FOLINATO DE CALCIO TABLETAS Autor / Dependencia: Dirección de Medicamentos y Tecnologías en Salud Ciudad: Bogotá Fecha: 08/09/2016. 2016;
FEDERACIÓN INTERNACIONAL DE FARMACIA. Informe De La Cumbre Internacional Sobre Desabastecimiento De Medicamentos. FIP- Toronto Canadá [Internet]. 2013;1–26. Available from: https://www.fip.org/files/fip/publications/P02595_FIP_Summit_on_Medicines_Shortage-Spaans_TAB_V3_LOS.pdf
Fox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. Am J Heal Pharm. 2018;
Fox ER, Pugh MJ, Karnad AB, Parsons HM, Liang Y, Schmidt S. ReCAP: Association Between the Number of Suppliers for Critical Antineoplastics and Drug Shortages: Implications for Future Drug Shortages and Treatment. J Oncol Pract. 2016;
Fox ER, Sweet B V., Jensen V. Drug shortages: A complex health care crisis. Mayo Clinic Proceedings. 2014.
Fox ER, Tyler LS. Potential Association between Drug Shortages and High-Cost Medications. Pharmacotherapy [Internet]. 2016; Available from: http://www.ncbi.nlm.nih.gov/pubmed/27891635
Frey NP, Davis EP. Launch and commissioning the deep space climate observatory. Adv Astronaut Sci. 2016;157(February):999–1010
Giovanella, L., Feo, O., Faria, M., Tobar S. Sistemas de Salud en Suramérica [Internet]. UNASUR,Instituto Suramericano de Gobierno en Salud. 2012. 854 p. Available from: http://www.isags-unasur.org/uploads/biblioteca/2/bb[8]ling[2]anx[9].pdf
Goldsack JC, Reilly C, Bush C, McElligott S, Bristol MN, Motanya UN, et al. Impact of shortages of injectable oncology drugs on patient care. Am J Heal Pharm. 2014;
Group AP. Why drug shortages occur. Drug Ther Bull [Internet]. 2015;53(3):33–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929429250&doi=10.1136%2Fdtb.2015.3.0316&partnerID=40&md5=856988f7216a695184ada98b06229765%0Ahttp://dtb.bmj.com/cgi/doi/10.1136/dtb.2015.3.0316
GUERRERO J. ASPECTOS TEÓRICOS PARA EL ESTABLECIMIENTO DE POSIBLES ESTRATEGIAS DE MEJORAMIENTO PARA LA PRESTACIÓN DEL SERVICIO DE SALUD EN COLOMBIA BASADO EN LA LEY ESTATUTARIA EN SALUD 1751 DEL 2015. 2018;
Guerrero R, Gallego AI, Becerril-Montekio V, Vásquez J. Sistema de salud de Colombia. Salud Publica Mex. 2011;53(SUPPL. 2).
Guillén Ponces, Carmen (Servicio de Oncología Médica. Hospital Ramón y Cajal. Madrid); Molina Garrido MJ( S de OMHV de la LC. Qué es, cómo funciona y tipos de quimioterapia. SEOM “Sociedad Española de Oncología Médica.” 2014
Harris RC, Dodd PJ, White RG. The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality. BMC Med. 2016;
Hedlund NG, Isgor Z, Zwanziger J, Rondelli D, Crawford SY, Hynes DM, et al. Drug Shortage Impacts Patient Receipt of Induction Treatment. Health Serv Res. 2018;
Hernandez Sampieri R, Fernandez Collado C, Baptista Lucio M del P. Metodología de La Investigación. Quinta Edición. Metodol la Investig. 2010;
Hipocrate E, Hoffman B, Schorge J, Cunningham F, Carol U, București D, et al. Williams Ginecologie Tratat și atlas color de tehnici chirurgicale Cuprinsul lucr ării. 2015;
Investigación y Ciencia. Manual de Procedimientos. Med Soc. 2005;126(5):419–22.
ISAGS. Situation of Essential Medicines at Risk of Supply Shortage with Emphasis on South American Countries. Rio de Janeiro; 2017.
ISAGS-UNASUR. Situación de medicamentos esenciales con riesgo de desabastecimiento con énfasis en los países Suramericanos. Available online at: http://isags-unasur.org/es/publicacao/situacion-de-medicamentos-esenciales-con-riesgo-de-desabastecimiento-con-enfasis-en-los-paises-suramericanos/. 2017.
Iyengar S, Hedman L, Forte G, Hill S. Medicine shortages: A commentary on causes and mitigation strategies. BMC Med [Internet]. 2016;14(1):1–3. Available from: http://dx.doi.org/10.1186/s12916-016-0674-7
Jia J, Zhao H. Mitigating the U.S. Drug Shortages Through Pareto-Improving Contracts. Prod Oper Manag. 2017;26(8):1463–80.
Kehl KL, Gray SW, Kim B, Kahn KL, Haggstrom D, Roudier M, et al. Oncologists’ Experiences With Drug Shortages. J Oncol Pract [Internet]. 2015;11(2):e154–62. Available from: http://ascopubs.org/doi/10.1200/JOP.2014.000380
Kim P, Simoens S, Casteels M, Huys I. Insights into european drug shortages: A survey of hospital pharmacists. PLoS One. 2015;10(3):1–13.
Li E, Subramanian J, Anderson S, Thomas D, McKinley J, Jacobs IA. Development of biosimilars in an era of oncologic drug shortages. Drug Design, Development and Therapy. 2015.
Lukmanji S, Sauro KM, Josephson CB, Altura KC, Wiebe S, Jetté N. A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy. Epilepsia. 2018;59(2):468–78.
Mankiw G. La oferta, la demanda y el mercado. In: Principios de economía. 2011.
Matínez Bencardino C, Bolker BM, Brooks ME, Clark CJ, Geange SW, Poulsen JR, et al. Estadística básica aplicada (4a.ed.). Behavioral Research Data Analysis with R SE - 3. 2011.
Mazer-Amirshahi M, Hawley KL, Zocchi M, Fox E, Pines JM, Nelson LS. Drug shortages: Implications for medical toxicology. Clin Toxicol [Internet]. 2015 Jul 3 [cited 2019 Feb 11];53(6):519–24. Available from: http://www.tandfonline.com/doi/full/10.3109/15563650.2015.1043441
McBride A, Holle LM, Westendorf C, Sidebottom M, Griffith N, Muller RJ, et al. National survey on the effect of oncology drug shortages on cancer care. Am J Heal Pharm. 2013;
McLaughlin MM, Skoglund EW. Drug Shortages and Patient Safety: An Overview of Essential Information for the Infusion Nurse. J Infus Nurs. 2015;38(3):205–8.
Meloni ST, Chaplin B, Idoko J, Agbaji O, Akanmu S, Imade G, et al. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program. AIDS Res Ther. 2017;
Melorose J, Perroy R, Careas S. DECRETO NÚMERO 677 DE 1995. Statew Agric L Use Baseline 2015. 2015;
MINISTERIO DE LA PROTECCIÓN SOCIAL. RESOLUCION 1043 de 2006. Minist la Protección Soc. 2006;
Ministerio de Salud y Protección Social. Resolucion 2003 de 2014. Minist La Protección Soc. 2014;
Ministerio de Salud y Protección Social. Repúlica de Colombia. Sistema de Información de Precios de Medicamentos (SISMED). 2015;
Morris S. Editorial: Medicine shortages in Australia - what are we doing about them? Aust Prescr. 2018;41(5):136–7.
Murcia E, Aguilera J, Wiesner C, Pardo C. Oncology services supply in Colombia. Colomb Med. 2018;49(1):89–96.
N.J. N, T.H. L. The drug shortage crisis in the united states: impact on cancer pharmaceutical safety. Cancer Treatment and Research. 2019.
Neff MP, Wagner D, Phillips BJ, Shanks A, Thompson A, Wilkins K, et al. Propofol drug shortage associated with worse postoperative nausea and vomiting outcomes despite a mitigation strategy. AANA J. 2018;
Nonzee NJ, Luu TH. Cancer Policy: Pharmaceutical Safety [Internet]. Vol. 171. Springer International Publishing; 2019. 75–92 p. Available from: http://link.springer.com/10.1007/978-3-319-43896-2
Oscanoa TJ. Acceso y usabilidad de medicamentos: propuesta para una definición operacional. Rev Peru Med Exp Salud Publica. 2012
Otzen T, Manterola C. Técnicas de Muestreo sobre una Población a Estudio. Int J Morphol. 2017;
Paparella SF. Drug Shortages in the Emergency Department: Managing a Threat to Patient Safety. J Emerg Nurs. 2012;
Pauwels K, Huys I, Casteels M, Simoens S. Drug shortages in European countries: A trade-off between market attractiveness and cost containment? BMC Health Serv Res. 2014;
Pham MT, Greig JD, Sargeant JM, Mcewen SA. A scoping review of scoping reviews : advancing the approach and enhancing the consistency. 2015;(June 2014).
Pineda Velandia LA. Desabastecimiento de Medicamentos Esenciales: Una Herramienta para Identificar Casos Puntuales Basada en la Experiencia de Medicamentos Oncológicos de Primera Línea. 2015;
Rathmell WK, Jagsi R, Grubbs S, Bradbury A, Peppercorn J, Spence R, et al. Ethical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages. Oncologist. 2014;
Reed BN, Fox ER, Konig M, Jackevicius CA, Masoudi FA, Rabinstein AA, et al. The impact of drug shortages on patients with cardiovascular disease: Causes, consequences, and a call to action. American Heart Journal. 2016.
Romito B, Stone J, Ning N, Yin C, Llano EM, Liu J, et al. How Drug Shortages Affect Clinical Care: The Case of the Surgical Anesthetic Propofol. Hosp Pharm. 2015;
Rose AJ. Targeted approaches to improve outcomes for highest-cost patients. Isr J Health Policy Res. 2017;6(1):6–8.
Saedi S, Erhun Kundakcioglu O, Henry AC. Mitigating the impact of drug shortages for a healthcare facility: An inventory management approach. Eur J Oper Res [Internet]. 2016;251(1):107–23. Available from: http://dx.doi.org/10.1016/j.ejor.2015.11.017
Schwartzberg E, Ainbinder D, Vishkauzan A, Gamzu R. Drug shortages in Israel : regulatory perspectives , challenges and solutions. 2017;1–8.
Scott JC, Shah N, Porco T, Flood J. Cost resulting from anti-tuberculosis drug shortages in the United States: A hypothetical cohort study. PLoS One. 2015;
Secretaría I De. La escasez mundial de medicamentos y la seguridad y accesibilidad de los medicamentos pediátricos. 2016;2:153–4.
Setayesh S, Mackey TK. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: Promoting access to medicines and health diplomacy. Global Health. 2016;
Skelton Duke M, Chambliss WG, Gardner KN, Norris DM. Mitigating the impact of medication shortages on public health. J Am Pharm Assoc. 2011;
Steers WD. Falling Short: Causes and Implications of Drug Shortages in the United States. J Urol. 2014;
Storey MA, Weber RJ, Besco K, Beatty S, Aizawa K, Mirtallo JM. Evaluation of Parenteral Nutrition Errors in an Era of Drug Shortages. Nutr Clin Pract. 2016;31(2):211–7.
Tan YX, Moles RJ, Chaar BB. Medicine shortages in Australia: causes, impact and management strategies in the community setting. Int J Clin Pharm. 2016;38(5):1133–41.
Tapella E. El mapeo de actores claves. Efectos de la biodiversidad funcional sobre procesos ecosistémicos, servicios ecosistémicos y sustentabilidad en las Américas: un abordaje interdisciplinario. 2007
Therapeutic Goods Administration T. Medicine Shortages Information Initiative [Internet]. 2019 [cited 2019 Apr 2]. Available from: https://apps.tga.gov.au/prod/MSI/search#furtherinformation
Ventola CL. The Drug Shortage Crisis in the United States Causes , Impact , and Management Strategies. 2011;36(11).
Videau M, Lebel D, Bussières JF. Drug shortages in Canada: Data for 2016–2017 and perspectives on the problem. Ann Pharm Fr [Internet]. 2019; Available from: https://doi.org/10.1016/j.pharma.2018.11.007
WHO. WHOCC - ATC DDD Index. WHO Collab Cent Drug Stat Methodol. 2018;
Ziesenitz VC, Fox E, Zocchi M, Samiee-Zafarghandy S, van den Anker JN, Mazer-Amirshahi M. Prescription Drug Shortages: Impact on Neonatal Intensive Care. Neonatology [Internet]. 2019 [cited 2019 Feb 11];108–15. Available from: https://www.karger.com/Article/FullText/493119
dc.rights.spa.fl_str_mv Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
rights_invalid_str_mv Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales
https://creativecommons.org/licenses/by-nc-sa/4.0/
Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.coverage.spatial.spa.fl_str_mv Bogotá, Colombia
dc.publisher.spa.fl_str_mv Bogotá : Universidad de Ciencias Aplicadas y Ambientales, 2019
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias
dc.publisher.program.spa.fl_str_mv Química Farmacéutica
institution Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
bitstream.url.fl_str_mv https://repository.udca.edu.co/bitstreams/c8c88cb2-68e5-4230-b249-e14cc08b6e7a/download
https://repository.udca.edu.co/bitstreams/3cc59eeb-075d-4c32-bd23-737974afae48/download
https://repository.udca.edu.co/bitstreams/7e59a220-7889-4d6d-b602-f824cccf1317/download
https://repository.udca.edu.co/bitstreams/c99c8ce5-95d6-4e95-9739-c4878a3faf45/download
bitstream.checksum.fl_str_mv 75aa1534b86cd9e04b57f68924ff47a9
f661acf14bedbf9f5d13897a0387e751
ba1441070c4defb4c00ac5d8bc43c259
cb4a0079970962b1feb6a66aadc73e43
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio - Universidad de Ciencias Aplicadas y Ambientales UDCA.
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1814213210903937024
spelling Vanegas Escamilla, Egdda Patricia, dir.Linares González, Yanis MilenaAguilar Rodriguez, Argelis MairenaBogotá, Colombia2019-08-12T22:38:25Z2019-08-12T22:38:25Z2019https://repository.udca.edu.co/handle/11158/1953QF045 L35e 2019 (205619)132 páginas : gráficasEl desabastecimiento de medicamentos ha generado un problema de salud mundial que se ha evidenciado en un gran número de países, esto ha tenido consecuencias negativas en la calidad y la eficiencia en la atención de los pacientes. La Organización Mundial de la Salud -OMS establece que el desabastecimiento se produce cuando el suministro de medicamentos esenciales en un sistema de salud se considera insuficiente para satisfacer las necesidades de salud pública y de los pacientes. En Colombia, el INVIMA define el desabastecimiento como la situación en la cual se presenta una insuficiente oferta para satisfacer la demanda de un producto farmacéutico que ya ha sido aprobado por el INVIMA y comercializado en el país; las causas de la escasez se han analizado en varios países y numerosos estudios; dentro de las cuales se han identificado: aspectos regulatorios, problemas de producción, inadecuada gestión logística y problemas específicos de oferta y demanda. Actualmente en Colombia y en Latinoamérica no se han evidenciado investigaciones acerca de las consecuencias generadas por el desabastecimiento. Este estudio tiene como objetivo establecer las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de Bogotá. Con el fin de identificar y documentar las consecuencias, se planteó realizar una investigación de carácter mixto, donde se realizaron entrevistas semi-estructuradas a expertos que han tenido contacto con el fenómeno del desabastecimiento con el fin de obtener información preliminar acerca de las consecuencias generadas a causa del desabastecimiento, posteriormente se diseñó y distribuyo una encuesta a los servicios farmacéuticos de Bogotá que ofrecen servicios de quimioterapia y se realizó un análisis estadístico a las encuestas realizadas para determinar la ocurrencia de los eventos evidenciados, finalmente se determinó el efecto del desabastecimiento de medicamentos oncológicos de los servicios farmacéuticos de Bogotá a través de un constructo. De acuerdo con los resultados se identificaron consecuencias como aumento de costos administrativos en procesos de compra 76%, aumento de los costos del servicio farmacéutico 34%, aumentos de costos de hospitalización 21%, aumento de costos por el tiempo del personal 38%, aumento significativo en el precio de los medicamentos 72%, a nivel institucional las entidades se han visto afectadas por imagen y PQR 28%, cambios entre contratación de IPS y EPS 45%, por el aumento del tiempo del personal del servicio farmacéutico, atraso en las tareas asignadas al personal 31% y generación de nuevos procesos 10% , en cuanto a afectación en la salud se identificaron complicaciones que requieren hospitalización 24%, nuevos exámenes clínicos 21% y reingresos al hospital 10%, el uso de alternativas terapéuticas menos efectivas, 28%, cambios en protocolos, 14%, interrupción y cambios en el tratamiento, 10%, sustitución de medicamentos 69%, errores de medicación 31%, cambios en la formulación que causan problemas de seguridad en los pacientes 62%, efectos negativos en los resultados de la terapia 31%, mortalidad 45% y finalmente los medicamentos que son desabastecidos con frecuencia 5-fluoracilo 24%, metrotexato 22%, calcio folinato 22%, Cisplatino 12%, letrosol 8% y doxorrubicina 4% en forma farmacéutica afectada inyectable 82% y Orales 8%.The shortage of medicines has generated a global health problem that has been evident in a large number of countries, this has had negative consequences on the quality and efficiency of patient care. The World Health Organization - OMS states that the shortage occurs when the supply of essential drugs in a health system is considered insufficient to meet the needs of public health and patients. In Colombia, INVIMA defines shortages as the situation in which an insufficient supply is presented to meet the demand for a pharmaceutical product that has already been approved by INVIMA and marketed in the country; The causes of the shortage have been analyzed in several countries and numerous studies; Within which have been identified: regulatory aspects, production problems, inadequate logistics management and specific supply and demand problems. Currently, in Colombia and Latin America there have been no investigations into the consequences generated by the shortage. This study aims to establish the consequences of the shortage of oncological drugs in the pharmaceutical services of Bogotá. In order to identify and document the consequences, a mixed investigation was carried out, where semi-structured interviews were conducted with experts who had contact with the phenomenon of shortage in order to obtain preliminary information about the consequences generated by Because of the shortage, a survey was designed and distributed to the pharmaceutical services of Bogotá that offer chemotherapy services and a statistical analysis was carried out to the surveys carried out to determine the occurrence of the evidenced events, finally the effect of the shortage of medicines was determined oncology of the pharmaceutical services of Bogotá through a construct. According to the results, consequences were identified such as an increase in administrative costs in purchasing processes 76%, increase in the costs of the pharmaceutical service 34%, increases in hospitalization costs 21%, increase in costs due to staff time 38%, increase Significant in the price of medicines 72%, at institutional level the entities have been affected by image and PQR 28%, changes between hiring IPS and EPS 45%, due to the increase in the time of the personnel of the pharmaceutical service, delay in the tasks assigned to staff 31% and generation of new processes 10%, in terms of health involvement complications were identified that require 24% hospitalization, new clinical exams 21% and re-hospitalizations 10%, the use of less effective therapeutic alternatives, 28%, changes in protocols, 14%, interruption and changes in treatment, 10%, medication substitution 69%, medication errors 31%, changes in the form ulation that cause safety problems in patients 62%, negative effects on the results of therapy 31%, mortality 45% and finally medications that are frequently depleted 5-fluoracil 24%, metrotexate 22%, calcium folinate 22%, Cisplatin 12%, letrosol 8% and doxorubicin 4% in affected pharmaceutical form 82% injectable and Oral 8%.Incluye bibliografíaPregradoQuímico(a) Farmacéuticoapplication/pdfspaBogotá : Universidad de Ciencias Aplicadas y Ambientales, 2019Facultad de CienciasQuímica FarmacéuticaDerechos Reservados - Universidad de Ciencias Aplicadas y Ambientaleshttps://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccessAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)http://purl.org/coar/access_right/c_abf2Farmacoterapia oncológicaAgentes neoplásicosMedicamentos - Abastecimiento y distribuciónEvaluación de las consecuencias del desabastecimiento de medicamentos oncológicos en los servicios farmacéuticos de BogotáTrabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1finfo:eu-repo/semantics/bachelorThesisinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/TPhttp://purl.org/coar/version/c_970fb48d4fbd8a85Drug shortages roundtable: Minimizing the impact on patient care. Am J Heal Pharm[Internet]. 2018 Jun 1 [cited 2019 Feb 11];75(11):816–20. Available from: https://academic.oup.com/ajhp/article/75/11/816-820/5102302Servicios Oncológicos en Colombia. Rev Colomb Cancerol. 2013;14(1):52.A ALPS. Título: REPORTE DE CASO DESABASTECIMIENTO Metotrexato 500 mg inyectable Autor / Dependencia: Dirección de Medicamentos y Tecnologías en Salud Ciudad: Bogotá Fecha: 28/12/2017. 2017;28–9.Aguilar Gavira S, Barroso Osuna J. La triangulación de datos como estrategia en investigación educativa. Píxel-Bit, Rev Medios y Educ. 2015;Alevizakos M, Detsis M, Grigoras CA, Machan JT, Mylonakis E. The Impact of Shortages on Medication Prices: Implications for Shortage Prevention. Drugs. 2016;76(16):1551–8.Alruthia YS, Alwhaibi M, Alotaibi MF, Asiri SA, Alghamdi BM, Almuaythir GS, et al. Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi Pharm J [Internet]. 2018;26(7):947–51. Available from: https://doi.org/10.1016/j.jsps.2018.05.002AlRuthia YS, AlKofide H, AlAjmi R, Balkhi B, Alghamdi A, AlNasser A, et al. Drug shortages in large hospitals in Riyadh: a cross-sectional study. Ann Saudi Med [Internet]. 2017 Sep [cited 2019 Feb 11];37(5):375–85. Available from: http://www.annsaudimed.net/index.php/vol37/vol37iss5/4657.htmlAlsheikh M, Seoane-Vazquez E, Rittenhouse B, Fox ER, Fanikos J. A Comparison of Drug Shortages in the Hospital Setting in the United States and Saudi Arabia: An Exploratory Analysis. Hosp Pharm [Internet]. 2016;51(5):370–5. Available from: http://journals.sagepub.com/doi/10.1310/hpj5105-370American College of Medical Toxicology, American Academy of Clinical Toxicology. Antidote Shortages in the USA: Impact and Response. J Med Toxicol. 2015;11(1):144–6.Asamblea Mundial de la Salud 70. La escasez mundial de medicamentos y vacunas y el acceso a ellos: informe de la Secretaría. 2017;2:1–9. Available from: http://apps.who.int/iris/handle/10665/274800%0Ahttp://apps.who.int/iris/bitstream/10665/274800/1/A70_20-sp.pdfBigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2013;Bochenek T, Abilova V, Alkan A, Asanin B, Beriain I de M, Besovic Z, et al. Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian Countries. Front Pharmacol. 2018;8(JAN).Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, et al. Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa. Trop Med Int Heal. 2017;Cáncer DEL. Plan Decena Para El Control Del Cáncer En Colombia 2012-2021 [Internet]. 2012. Available from: https://www.minsalud.gov.co/Documentos y Publicaciones/Plan Decenal para el Control del Cáncer.pdfCasas Anguita J, Repullo Labrador JR, Donado Campos J. La encuesta como técnica de investigación. Elaboración de cuestionarios y tratamiento estadístico de los datos (I). Aten Primaria. 2003;Castellanos L. EVOLUCIÓN DEL MERCADO FARMACÉUTICO CON RELACIÓN AL DESABASTECIMIENTO DE LOS MEDICAMENTOS ONCOLÓGICOS EN COLOMBIA. 2019;Castrellón-Torres JP, Torres-Acosta JH, Adarme-Jaimes W. Model for the logistics distribution of medicines in the Colombian public health program. DYNA. 2014;Caulder C, Mehta B, Bookstaver P, Sims L, Stevenson B, South Carolina Society of Health-Sy. Impact of Drug Shortages on Health System Pharmacies in the Southeastern United States. Hosp Pharm [Internet]. 2015;50(4):279–86. Available from: http://archive.hospital-pharmacy.com/doi/abs/10.1310/hpj5004-279Ceballos MM. Manual para el desarrollo del mapeo de actores claves–MAC. Elabor en el marco la Consult técnica GITEC-SERCITEC. 2004;Chen SI. Economic benefits of sharing and redistributing influenza vaccines when shortages occurred. PLoS One. 2017;Choi JB, Rogers J, Jones EC. The impact of a shared pharmaceutical supply chain model on counterfeit drugs, diverted drugs, and drug shortages. In: Portland International Conference on Management of Engineering and Technology. 2015.Claus B, Bauters T, Laureys G. Drug shortages in a pediatric stem cell transplantation ward: Challenges and implications. A 5-year bilan. J Oncol Pharm Pract. 2018;Claus B, Pauwels K, Baert M, Depoorter J, De Weerdt E, Boussery K, et al. [Drug shortages in the hospital: management, causes and budget impact]. J Pharm Belg. 2015;De Weerdt E, De Rijdt T, Simoens S, Casteels M, Huys I. Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study. PLoS One. 2017;De Weerdt E, Simoens S, Casteels M, Huys I. Clinical, Economic and Policy Implications of Drug Shortages in the European Union. Appl Health Econ Health Policy. 2017;15(4):441–5.De Weerdt E, Simoens S, Casteels M, Huys I. Toward a European definition for a drug shortage: A qualitative study. Front Pharmacol. 2015;de Weerdt E, Simoens S, Casteels M, Huys I. Clinical, Economic and Policy Implications of Drug Shortages in the European Union. Appl Health Econ Health Policy. 2016;1–5.De Weerdt E, Simoens S, Hombroeckx L, Casteels M, Huys I. Causes of drug shortages in the legal pharmaceutical framework. Regul Toxicol Pharmacol [Internet]. 2015;71(2):251–8. Available from: http://dx.doi.org/10.1016/j.yrtph.2015.01.005De I. Informe de gestión del desabastecimiento de medicamentos en Colombia 2013-2018. 2018;Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG. Drug tendering: Drug supply and shortage implications for the uptake of biosimilars. ClinicoEconomics and Outcomes Research. 2017.Estadístico De Datos A, Franco TL, Hidalgo R. Análisis Estadístico de Datos de Caracterización Morfológica de Recursos Fitogenéticos. Boletin Técnico Nro 8, Instituto Internacional de Recursos Fitogenéticos IPGRI. 2003Fecha M, Suministro D, Esmeralda ASA, Regulatory AM, Manager A, M- I, et al. Título: REPORTE DE CASO DESABASTECIMIENTO FOLINATO DE CALCIO TABLETAS Autor / Dependencia: Dirección de Medicamentos y Tecnologías en Salud Ciudad: Bogotá Fecha: 08/09/2016. 2016;FEDERACIÓN INTERNACIONAL DE FARMACIA. Informe De La Cumbre Internacional Sobre Desabastecimiento De Medicamentos. FIP- Toronto Canadá [Internet]. 2013;1–26. Available from: https://www.fip.org/files/fip/publications/P02595_FIP_Summit_on_Medicines_Shortage-Spaans_TAB_V3_LOS.pdfFox ER, McLaughlin MM. ASHP guidelines on managing drug product shortages. Am J Heal Pharm. 2018;Fox ER, Pugh MJ, Karnad AB, Parsons HM, Liang Y, Schmidt S. ReCAP: Association Between the Number of Suppliers for Critical Antineoplastics and Drug Shortages: Implications for Future Drug Shortages and Treatment. J Oncol Pract. 2016;Fox ER, Sweet B V., Jensen V. Drug shortages: A complex health care crisis. Mayo Clinic Proceedings. 2014.Fox ER, Tyler LS. Potential Association between Drug Shortages and High-Cost Medications. Pharmacotherapy [Internet]. 2016; Available from: http://www.ncbi.nlm.nih.gov/pubmed/27891635Frey NP, Davis EP. Launch and commissioning the deep space climate observatory. Adv Astronaut Sci. 2016;157(February):999–1010Giovanella, L., Feo, O., Faria, M., Tobar S. Sistemas de Salud en Suramérica [Internet]. UNASUR,Instituto Suramericano de Gobierno en Salud. 2012. 854 p. Available from: http://www.isags-unasur.org/uploads/biblioteca/2/bb[8]ling[2]anx[9].pdfGoldsack JC, Reilly C, Bush C, McElligott S, Bristol MN, Motanya UN, et al. Impact of shortages of injectable oncology drugs on patient care. Am J Heal Pharm. 2014;Group AP. Why drug shortages occur. Drug Ther Bull [Internet]. 2015;53(3):33–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929429250&doi=10.1136%2Fdtb.2015.3.0316&partnerID=40&md5=856988f7216a695184ada98b06229765%0Ahttp://dtb.bmj.com/cgi/doi/10.1136/dtb.2015.3.0316GUERRERO J. ASPECTOS TEÓRICOS PARA EL ESTABLECIMIENTO DE POSIBLES ESTRATEGIAS DE MEJORAMIENTO PARA LA PRESTACIÓN DEL SERVICIO DE SALUD EN COLOMBIA BASADO EN LA LEY ESTATUTARIA EN SALUD 1751 DEL 2015. 2018;Guerrero R, Gallego AI, Becerril-Montekio V, Vásquez J. Sistema de salud de Colombia. Salud Publica Mex. 2011;53(SUPPL. 2).Guillén Ponces, Carmen (Servicio de Oncología Médica. Hospital Ramón y Cajal. Madrid); Molina Garrido MJ( S de OMHV de la LC. Qué es, cómo funciona y tipos de quimioterapia. SEOM “Sociedad Española de Oncología Médica.” 2014Harris RC, Dodd PJ, White RG. The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality. BMC Med. 2016;Hedlund NG, Isgor Z, Zwanziger J, Rondelli D, Crawford SY, Hynes DM, et al. Drug Shortage Impacts Patient Receipt of Induction Treatment. Health Serv Res. 2018;Hernandez Sampieri R, Fernandez Collado C, Baptista Lucio M del P. Metodología de La Investigación. Quinta Edición. Metodol la Investig. 2010;Hipocrate E, Hoffman B, Schorge J, Cunningham F, Carol U, București D, et al. Williams Ginecologie Tratat și atlas color de tehnici chirurgicale Cuprinsul lucr ării. 2015;Investigación y Ciencia. Manual de Procedimientos. Med Soc. 2005;126(5):419–22.ISAGS. Situation of Essential Medicines at Risk of Supply Shortage with Emphasis on South American Countries. Rio de Janeiro; 2017.ISAGS-UNASUR. Situación de medicamentos esenciales con riesgo de desabastecimiento con énfasis en los países Suramericanos. Available online at: http://isags-unasur.org/es/publicacao/situacion-de-medicamentos-esenciales-con-riesgo-de-desabastecimiento-con-enfasis-en-los-paises-suramericanos/. 2017.Iyengar S, Hedman L, Forte G, Hill S. Medicine shortages: A commentary on causes and mitigation strategies. BMC Med [Internet]. 2016;14(1):1–3. Available from: http://dx.doi.org/10.1186/s12916-016-0674-7Jia J, Zhao H. Mitigating the U.S. Drug Shortages Through Pareto-Improving Contracts. Prod Oper Manag. 2017;26(8):1463–80.Kehl KL, Gray SW, Kim B, Kahn KL, Haggstrom D, Roudier M, et al. Oncologists’ Experiences With Drug Shortages. J Oncol Pract [Internet]. 2015;11(2):e154–62. Available from: http://ascopubs.org/doi/10.1200/JOP.2014.000380Kim P, Simoens S, Casteels M, Huys I. Insights into european drug shortages: A survey of hospital pharmacists. PLoS One. 2015;10(3):1–13.Li E, Subramanian J, Anderson S, Thomas D, McKinley J, Jacobs IA. Development of biosimilars in an era of oncologic drug shortages. Drug Design, Development and Therapy. 2015.Lukmanji S, Sauro KM, Josephson CB, Altura KC, Wiebe S, Jetté N. A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy. Epilepsia. 2018;59(2):468–78.Mankiw G. La oferta, la demanda y el mercado. In: Principios de economía. 2011.Matínez Bencardino C, Bolker BM, Brooks ME, Clark CJ, Geange SW, Poulsen JR, et al. Estadística básica aplicada (4a.ed.). Behavioral Research Data Analysis with R SE - 3. 2011.Mazer-Amirshahi M, Hawley KL, Zocchi M, Fox E, Pines JM, Nelson LS. Drug shortages: Implications for medical toxicology. Clin Toxicol [Internet]. 2015 Jul 3 [cited 2019 Feb 11];53(6):519–24. Available from: http://www.tandfonline.com/doi/full/10.3109/15563650.2015.1043441McBride A, Holle LM, Westendorf C, Sidebottom M, Griffith N, Muller RJ, et al. National survey on the effect of oncology drug shortages on cancer care. Am J Heal Pharm. 2013;McLaughlin MM, Skoglund EW. Drug Shortages and Patient Safety: An Overview of Essential Information for the Infusion Nurse. J Infus Nurs. 2015;38(3):205–8.Meloni ST, Chaplin B, Idoko J, Agbaji O, Akanmu S, Imade G, et al. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program. AIDS Res Ther. 2017;Melorose J, Perroy R, Careas S. DECRETO NÚMERO 677 DE 1995. Statew Agric L Use Baseline 2015. 2015;MINISTERIO DE LA PROTECCIÓN SOCIAL. RESOLUCION 1043 de 2006. Minist la Protección Soc. 2006;Ministerio de Salud y Protección Social. Resolucion 2003 de 2014. Minist La Protección Soc. 2014;Ministerio de Salud y Protección Social. Repúlica de Colombia. Sistema de Información de Precios de Medicamentos (SISMED). 2015;Morris S. Editorial: Medicine shortages in Australia - what are we doing about them? Aust Prescr. 2018;41(5):136–7.Murcia E, Aguilera J, Wiesner C, Pardo C. Oncology services supply in Colombia. Colomb Med. 2018;49(1):89–96.N.J. N, T.H. L. The drug shortage crisis in the united states: impact on cancer pharmaceutical safety. Cancer Treatment and Research. 2019.Neff MP, Wagner D, Phillips BJ, Shanks A, Thompson A, Wilkins K, et al. Propofol drug shortage associated with worse postoperative nausea and vomiting outcomes despite a mitigation strategy. AANA J. 2018;Nonzee NJ, Luu TH. Cancer Policy: Pharmaceutical Safety [Internet]. Vol. 171. Springer International Publishing; 2019. 75–92 p. Available from: http://link.springer.com/10.1007/978-3-319-43896-2Oscanoa TJ. Acceso y usabilidad de medicamentos: propuesta para una definición operacional. Rev Peru Med Exp Salud Publica. 2012Otzen T, Manterola C. Técnicas de Muestreo sobre una Población a Estudio. Int J Morphol. 2017;Paparella SF. Drug Shortages in the Emergency Department: Managing a Threat to Patient Safety. J Emerg Nurs. 2012;Pauwels K, Huys I, Casteels M, Simoens S. Drug shortages in European countries: A trade-off between market attractiveness and cost containment? BMC Health Serv Res. 2014;Pham MT, Greig JD, Sargeant JM, Mcewen SA. A scoping review of scoping reviews : advancing the approach and enhancing the consistency. 2015;(June 2014).Pineda Velandia LA. Desabastecimiento de Medicamentos Esenciales: Una Herramienta para Identificar Casos Puntuales Basada en la Experiencia de Medicamentos Oncológicos de Primera Línea. 2015;Rathmell WK, Jagsi R, Grubbs S, Bradbury A, Peppercorn J, Spence R, et al. Ethical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages. Oncologist. 2014;Reed BN, Fox ER, Konig M, Jackevicius CA, Masoudi FA, Rabinstein AA, et al. The impact of drug shortages on patients with cardiovascular disease: Causes, consequences, and a call to action. American Heart Journal. 2016.Romito B, Stone J, Ning N, Yin C, Llano EM, Liu J, et al. How Drug Shortages Affect Clinical Care: The Case of the Surgical Anesthetic Propofol. Hosp Pharm. 2015;Rose AJ. Targeted approaches to improve outcomes for highest-cost patients. Isr J Health Policy Res. 2017;6(1):6–8.Saedi S, Erhun Kundakcioglu O, Henry AC. Mitigating the impact of drug shortages for a healthcare facility: An inventory management approach. Eur J Oper Res [Internet]. 2016;251(1):107–23. Available from: http://dx.doi.org/10.1016/j.ejor.2015.11.017Schwartzberg E, Ainbinder D, Vishkauzan A, Gamzu R. Drug shortages in Israel : regulatory perspectives , challenges and solutions. 2017;1–8.Scott JC, Shah N, Porco T, Flood J. Cost resulting from anti-tuberculosis drug shortages in the United States: A hypothetical cohort study. PLoS One. 2015;Secretaría I De. La escasez mundial de medicamentos y la seguridad y accesibilidad de los medicamentos pediátricos. 2016;2:153–4.Setayesh S, Mackey TK. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: Promoting access to medicines and health diplomacy. Global Health. 2016;Skelton Duke M, Chambliss WG, Gardner KN, Norris DM. Mitigating the impact of medication shortages on public health. J Am Pharm Assoc. 2011;Steers WD. Falling Short: Causes and Implications of Drug Shortages in the United States. J Urol. 2014;Storey MA, Weber RJ, Besco K, Beatty S, Aizawa K, Mirtallo JM. Evaluation of Parenteral Nutrition Errors in an Era of Drug Shortages. Nutr Clin Pract. 2016;31(2):211–7.Tan YX, Moles RJ, Chaar BB. Medicine shortages in Australia: causes, impact and management strategies in the community setting. Int J Clin Pharm. 2016;38(5):1133–41.Tapella E. El mapeo de actores claves. Efectos de la biodiversidad funcional sobre procesos ecosistémicos, servicios ecosistémicos y sustentabilidad en las Américas: un abordaje interdisciplinario. 2007Therapeutic Goods Administration T. Medicine Shortages Information Initiative [Internet]. 2019 [cited 2019 Apr 2]. Available from: https://apps.tga.gov.au/prod/MSI/search#furtherinformationVentola CL. The Drug Shortage Crisis in the United States Causes , Impact , and Management Strategies. 2011;36(11).Videau M, Lebel D, Bussières JF. Drug shortages in Canada: Data for 2016–2017 and perspectives on the problem. Ann Pharm Fr [Internet]. 2019; Available from: https://doi.org/10.1016/j.pharma.2018.11.007WHO. WHOCC - ATC DDD Index. WHO Collab Cent Drug Stat Methodol. 2018;Ziesenitz VC, Fox E, Zocchi M, Samiee-Zafarghandy S, van den Anker JN, Mazer-Amirshahi M. Prescription Drug Shortages: Impact on Neonatal Intensive Care. Neonatology [Internet]. 2019 [cited 2019 Feb 11];108–15. Available from: https://www.karger.com/Article/FullText/493119PublicationORIGINALTRABAJO PROYECTO DE GRADO UDCA 28-07-2019.pdfTRABAJO PROYECTO DE GRADO UDCA 28-07-2019.pdfapplication/pdf2963667https://repository.udca.edu.co/bitstreams/c8c88cb2-68e5-4230-b249-e14cc08b6e7a/download75aa1534b86cd9e04b57f68924ff47a9MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-814775https://repository.udca.edu.co/bitstreams/3cc59eeb-075d-4c32-bd23-737974afae48/downloadf661acf14bedbf9f5d13897a0387e751MD52TEXTTRABAJO PROYECTO DE GRADO UDCA 28-07-2019.pdf.txtTRABAJO PROYECTO DE GRADO UDCA 28-07-2019.pdf.txtExtracted texttext/plain248059https://repository.udca.edu.co/bitstreams/7e59a220-7889-4d6d-b602-f824cccf1317/downloadba1441070c4defb4c00ac5d8bc43c259MD53THUMBNAILTRABAJO PROYECTO DE GRADO UDCA 28-07-2019.pdf.jpgTRABAJO PROYECTO DE GRADO UDCA 28-07-2019.pdf.jpgGenerated Thumbnailimage/jpeg3511https://repository.udca.edu.co/bitstreams/c99c8ce5-95d6-4e95-9739-c4878a3faf45/downloadcb4a0079970962b1feb6a66aadc73e43MD5411158/1953oai:repository.udca.edu.co:11158/19532024-05-09 14:21:26.455https://creativecommons.org/licenses/by-nc-sa/4.0/Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientalesopen.accesshttps://repository.udca.edu.coRepositorio - Universidad de Ciencias Aplicadas y Ambientales UDCA.bdigital@metabiblioteca.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